Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-thalassemia in Turkey.

R Oner1, C Altay, A Gurgey

  • 1Children's Center, Hacettepe University, Ankara, Turkey.

Hemoglobin
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endothelial ENaC as a repressor of oxidative stress and a guardian of lung capillary barrier function in bacterial and viral pneumonia.

Frontiers in physiology·2025
Same author

The clinical spectrum of HbSC sickle cell disease-not a benign condition.

British journal of haematology·2024
Same author

Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease.

Frontiers in health services·2023
Same author

A new sickling variant 'Hb S-Wake β[(Glu6Val-Asn139 Ser)]' found in a compound heterozygote with Hb S β(Glu6Val) coinherited with homozygous α-thalassemia-2: phenotype and molecular characteristics.

Acta haematologica·2010
Same author

Hb M Dothan [beta 25/26 (B7/B8)/(GGT/GAG-->GAG//Gly/Glu-->Glu]; a new mechanism of unstable methemoglobin variant and molecular characteristics.

Blood cells, molecules & diseases·2009
Same author

Spectrum, and clinical and functional implications of UNC13D mutations in familial haemophagocytic lymphohistiocytosis.

Journal of medical genetics·2007
Same journal

Compound Heterozygous Hemoglobin Minneapolis-Laos and Codon 41/42 (-TTCT) in a Thai Female Adult: A Case Report and Literature Review.

Hemoglobin·2026
Same journal

Hb F-SickKids (<i>HBG2</i>: C.308A > G): A Novel γ-Globin Variant Associated with Transient Neonatal Cyanosis.

Hemoglobin·2026
Same journal

Pyruvate Kinase Activation in the Management of Thalassemia and Sickle Cell Disease.

Hemoglobin·2026
Same journal

Genotypic Characterization of Hemoglobinopathies in Azerbaijan: A Review of 10 Years at a Referral Center.

Hemoglobin·2026
Same journal

Successful Management of Transfusion-Dependent Unstable Hemoglobin Perth with Splenectomy: First Report from Iran and Literature Review.

Hemoglobin·2026
Same journal

Unstable Hemoglobin Variants: Molecular Mechanisms, Clinical Phenotypes, and a Practical Diagnostic and Management Approach.

Hemoglobin·2026
See all related articles

This study identified 18 beta-thalassemia mutations in 191 patients, with six mutations causing 83% of abnormalities. Consanguinity drives homozygosity for common mutations like IVS-I-110, impacting disease severity.

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Beta-thalassemia is a significant inherited blood disorder.
  • Understanding the spectrum of beta-thalassemia mutations is crucial for genetic counseling and diagnosis.
  • High consanguinity rates in certain populations contribute to the prevalence of homozygous genetic disorders.

Purpose of the Study:

  • To review and characterize beta-thalassemia alleles in a cohort of patients with beta-thalassemia major.
  • To identify common and novel mutations responsible for beta-thalassemia.
  • To correlate specific genotypes with hematological phenotypes.

Main Methods:

  • Gene amplification techniques were employed for DNA analysis.
  • Dot-blot hybridization with synthetic probes was used to detect specific mutations.

Related Experiment Videos

  • Hematological data from patients and heterozygous relatives were compared.

    • Main Results:

    • Eighteen distinct beta-thalassemia mutations were identified among 191 patients and 182 relatives.
    • Six mutations accounted for approximately 83% of all observed beta-thalassemia abnormalities.
    • A novel G-to-C mutation at the IVS-I acceptor splice site was identified in a homozygous patient.
    • High consanguinity was linked to increased homozygosity for the IVS-I-110 (G-to-A) mutation.
    • Combinations of mutations and co-inheritance with abnormal hemoglobins (e.g., Hb S) were observed.
    • Specific heterozygotes showed distinct hematological profiles, including low Hb A2 in IVS-I-6 (T-to-C) and high Hb F in others.

    Conclusions:

    • The study provides a comprehensive overview of beta-thalassemia alleles in the studied population.
    • Genetic diversity and specific mutation combinations influence disease severity.
    • Consanguinity plays a significant role in the high frequency of certain homozygous beta-thalassemia mutations.
    • Distinct hematological parameters in heterozygotes can aid in carrier detection and understanding of allelic effects.